Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

Clinical trial NCT00055185 · COMPLETED

Trial details

NCT number: NCT00055185
Sponsor: Progenics Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Acquired Immune Deficiency Syndrome

Start date: 2003-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.